NewsBreak Original

# Biotech stocks

Mark Hake

Cassava Sciences Is Stock Worth Buying With a High Expected Return

2022-01-11

Related Contributors

Mark HakeMark Hake is a financial analyst, investor, and Chartered Financial Analyst (CFA). He writes about US and foreign stocks as well as cryptos, hedge funds, and private equity. He previously ran his own hedge fund, investment research firm, and acted as CFO for a fintech startup. He focuses on finding value, arbitrage, and hidden asset opportunities.